September 2018: NOhep Headlines

Welcome to your round-up of everything happening in the NOhep world! Read NOhep News in full here, or catch up with the headlines below.

Thank you for your continued support,

The NOhep Team

 

The NOhep Medical Visionaries Programme comes to Africa 

We are excited to announce that the NOhep Visionaries Programme for Medical Professionals in Africa was launched at the Conference on Liver Disease in Africa (COLDA), in Kenya, 13 – 15 September. The first conference of its kind, COLDA saw local liver experts come together to discuss how to prevent, treat and achieve a cure for liver disease in Africa. It was great to have a presence at this historic event.

Find out more here.

 

Australia surges forward in the “Race to 2030”

New data from the Kirby Institute has shown a 20% fall in deaths caused by hepatitis C in Australia. This decline comes after a large uptake in the use of direct-acting antiviral therapies, credited to successful price negotiations between the Australian government and pharmaceutical companies.

Find out more here.

 

NOhep Supporter Spotlight profile September 

This month’s Supporter Spotlight is Bisi Bright, CEO of LiveWell Initiative and a founder of Women in Hepatitis Africa (WIHA). A force to be reckoned with, Bisi is using her position as a women leader within the field of hepatitis to empower other women to take action for elimination in their communities.

We explore how WIHA operates as a group-targeted advocacy organisation working internationally across Africa, and how Bisi is using it to unleash the unique power of women to drive action.

Read Bisi’s profile here.

 

Potentially revolutionary diagnosis pilot starts in British Colombia 

A pilot in British Colombia is using a new $24 finger-prick test kit to screen people for hepatitis C. Called OraQuick HVC, the test is not only cheap but also quick to show results, doing so in as little as 20 minutes.

Find out more here.

 

We should all be a little more Su

NOhep supporter and Medical Visionary Su Wang taught us all a lesson in advocacy this month. Su met with and advocated her Senator to lift restrictions to access to hepatitis C treatment in the USA. Demanding action from our decision makers is key to our eliminating this global killer. Great work Su!

Follow Su’s work on Twitter here.

 

Read NOhep News in full here